Stem Cell Augmented, Elutriated Grafts for Allogeneic Bone Marrow Transplantation
OBJECTIVES:
- Determine whether stem cell augmented, elutriated grafts prevent graft versus host
disease in patients undergoing allogeneic bone marrow transplantation.
OUTLINE: Patients receive elutriated CD34+ augmented donor bone marrow on day 0.
Bone marrow samples are obtained before day 100, around 6 months, and 1 year after
transplant.
PROJECTED ACCRUAL: Not specified
Interventional
Primary Purpose: Supportive Care
Richard J. Jones, MD
Study Chair
Sidney Kimmel Comprehensive Cancer Center
United States: Federal Government
CDR0000066589, J9711
NCT00003538
March 1997
Name | Location |
---|---|
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore, Maryland 21231-2410 |